US Penny Stocks To Watch In November 2024

As of November 2024, the U.S. stock market is experiencing mixed movements, with investors closely watching major earnings reports and cryptocurrency trends. Despite the shifting landscape, certain investment opportunities remain intriguing for those willing to explore beyond traditional large-cap stocks. The term 'penny stocks' may seem outdated, yet these smaller or newer companies continue to offer potential growth when backed by strong financials. In this article, we will explore three penny stocks that stand out for their financial resilience and growth prospects in today's market climate.

Top 10 Penny Stocks In The United States

Name	Share Price	Market Cap	Financial Health Rating
BAB (OTCPK:BABB)	$0.8005	$6.01M	★★★★★★
QuantaSing Group (NasdaqGM:QSG)	$3.08	$144.65M	★★★★★★
Golden Growers Cooperative (OTCPK:GGRO.U)	$4.50	$69.71M	★★★★★★
PHX Minerals (NYSE:PHX)	$3.70	$133.43M	★★★★★☆
So-Young International (NasdaqGM:SY)	$1.25	$90.8M	★★★★☆☆
ZTEST Electronics (OTCPK:ZTST.F)	$0.21	$9.77M	★★★★★★
LexinFintech Holdings (NasdaqGS:LX)	$3.33	$529.41M	★★★★★★
Puma Biotechnology (NasdaqGS:PBYI)	$2.84	$134.5M	★★★★★★
Zynerba Pharmaceuticals (NasdaqCM:ZYNE)	$1.30	$65.6M	★★★★★☆
CBAK Energy Technology (NasdaqCM:CBAT)	$0.8518	$79.14M	★★★★★☆

Click here to see the full list of 742 stocks from our US Penny Stocks screener.

Below we spotlight a couple of our favorites from our exclusive screener.

Butterfly Network (NYSE:BFLY)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions globally with a market cap of $648.35 million.

Operations: The company generates revenue of $76.22 million from its AI-Enhanced Personal Ultrasound Solution segment.

Market Cap: $648.35M

Butterfly Network, Inc. has shown promising revenue growth, reporting US$20.56 million for Q3 2024, up from US$15.42 million a year ago, and reducing net losses significantly. The company increased its fiscal year 2024 revenue guidance to between US$79 million and US$81 million, indicating over 20% growth potential. Despite being unprofitable with a negative return on equity of -54.18%, Butterfly Network is debt-free and maintains sufficient cash runway for over a year. Recent strategic initiatives include the launch of advanced ultrasound technologies and partnerships enhancing global healthcare education access through AI-powered solutions like the HeartFocus Education app.

• Get an in-depth perspective on Butterfly Network's performance by reading our balance sheet health report here.
• Review our growth performance report to gain insights into Butterfly Network's future.

ATRenew (NYSE:RERE)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: ATRenew Inc. operates a platform for pre-owned consumer electronics transactions and services in China, with a market cap of approximately $539.93 million.

Operations: The company generates revenue primarily from its retail electronics segment, amounting to CN¥14.56 billion.

Market Cap: $539.93M

ATRenew Inc. has demonstrated financial improvement, reporting a net income of CN¥17.88 million for Q3 2024, reversing a loss from the previous year. The company's revenue is primarily driven by its retail electronics segment, amounting to CN¥14.56 billion annually. Despite being unprofitable overall, ATRenew has reduced losses over five years at an annual rate of 16.5%. The company holds more cash than debt and covers both short and long-term liabilities with substantial short-term assets (CN¥4.2 billion). While management is experienced, ongoing profitability challenges persist alongside stable weekly volatility in stock performance.

• Unlock comprehensive insights into our analysis of ATRenew stock in this financial health report.
• Explore ATRenew's analyst forecasts in our growth report.

DiDi Global (OTCPK:DIDI.Y)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: DiDi Global Inc. operates a mobility technology platform offering various services in China, Brazil, Mexico, and internationally with a market cap of approximately $23.24 billion.

Operations: The company's revenue is primarily derived from China Mobility, which accounts for CN¥181.67 billion, followed by Other Initiatives at CN¥9.72 billion and International operations contributing CN¥9.36 billion.

Market Cap: $23.24B

DiDi Global Inc. has recently achieved profitability, marking a significant turnaround with earnings forecast to grow 45.55% annually. The company maintains strong financial health, with short-term assets of CN¥66.2 billion exceeding both short-term and long-term liabilities, and more cash than total debt. Despite a large one-off loss impacting recent results, DiDi trades at 63% below its estimated fair value and is considered a good relative value compared to peers. However, the company's Return on Equity remains low at 1.9%, and its debt-to-equity ratio has increased over the past five years to 8.4%.

• Navigate through the intricacies of DiDi Global with our comprehensive balance sheet health report here.
• Gain insights into DiDi Global's outlook and expected performance with our report on the company's earnings estimates.

Key Takeaways

• Click this link to deep-dive into the 742 companies within our US Penny Stocks screener.
• Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up.
• Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world.

Contemplating Other Strategies?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Jump on the AI train with fast growing tech companies forging a new era of innovation.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com